October 12, 2017 / 8:48 AM / 6 months ago

CVC and Tethys Invest in exclusive talks for Sebia majority stake

LONDON (Reuters) - Buyout fund CVC Capital Partners’ strategic opportunities platform and the L’Oreal family’s Tethys Invest have entered exclusive talks to acquire a majority stake in France’s Sebia, the companies said on Thursday.

Founded in 1967, Sebia provides medical equipment and technology used for in-vitro diagnostic testing. It was acquired by Montagu Private Equity and Astorg Partners in 2014 for an undisclosed amount that sources put at around $1.4 billion.

    Tethys Invest was set up by Françoise Bettencourt Meyers and Jean-Pierre Meyers and is a subsidiary of the main shareholder of French cosmetics giant L’Oreal (OREP.PA).

    Reporting by Dasha Afanasieva; editing by Jason Neely

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below